Fara Brasó-Maristany

Fara Brasó-Maristany is a Researcher at the Hospital Clinic of Barcelona, specializing in translational genomics and targeted therapies for solid tumors, particularly breast cancer. She focuses on identifying biomarkers for treatment response and resistance mechanisms.

• Key Research Areas:
  • Breast Cancer
  • Translational Genomics
  • Targeted Therapies
  • Mechanisms of Resistance
  • Biomarker Discovery

Recent Research Trends: Her publications emphasize molecular profiling of breast cancer metastasis, ctDNA monitoring in CDK4/6 inhibitor therapy, HER2 blockade phenotypic changes, and PIM1 kinase's role in chemotherapy response. Keywords across her work include Oncology, Genomics, Immunotherapy, and Precision Medicine.

Projects: She leads an AECC-funded project (INVES21943BRAS) investigating therapeutic targets to overcome CDK4/6 inhibitor resistance in metastatic hormone receptor-positive HER2-negative breast cancer (2021-2024). Previously contributed to dual HER2 blockade mechanism studies (AECC Postdoctoral Grant 2017).

Labs/Teams: Collaborates with Aleix Prat's research group on translational breast cancer studies, working with multidisciplinary teams in molecular oncology and clinical trial biomarker analysis.